Aravax Appoints Louise Peacock as Chief Regulatory and Quality Officer as it Prepares for Phase 3 Development
June 02, 2025 04:00 ET Â | Source: Aravax MELBOURNE, Australia and OXFORD,…
Press Release Biocartis NV: Biocartis Announces IVDR Class C CDx Certification of the Idylla EGFR Mutation Test
PRESS RELEASE 02/06/2025, 10:00 CEST Biocartis Announces IVDR Class C CDx Certification…
Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
 Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease…
WISeKey to Present at Maxim Tech Conference Discover the Innovations Reshaping Tomorrow on June 3 at 8:30am ET
June 02, 2025 01:00 ET Â | Source: Wisekey International Holding Ltd. WISeKey…
KT&G Takes Legal Action Against Local Counterfeit Cigarette Manufacturers and Distributors in India
- Growing counterfeit cigarette manufacture and distribution leads to severe negative consequences…
Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment of Metastatic Pancreatic Cancer
Phase 2 (Actuate-1801 Part 3B) trial meets primary endpoint and demonstrates a…
Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma
Extended Phase 1b trial follow-up on IMA203 PRAME cell therapy in 33…
Rays Power Infra Ltd Achieves Record Revenue of 1350 Crore in FY25, Up 29% from Previous Year
NEW DELHI, May 30, 2025 /PRNewswire/ -- Rays Power Infra Limited, a…
Early Warning Press Release Respecting the Acquisition of Common Shares of RAMM PHARMA Corp.
TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- Jack Burnett ("CEO") today announced…
Celularity Receives Nasdaq Notice Regarding Form 10-Q
May 30, 2025 17:30 ET Â | Source: Celularity Inc. FLORHAM PARK, N.J.,…